1. Home
  2. OTEX vs CYTK Comparison

OTEX vs CYTK Comparison

Compare OTEX & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Open Text Corporation

OTEX

Open Text Corporation

N/A

Current Price

$25.01

Market Cap

8.1B

Sector

Technology

ML Signal

N/A

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

N/A

Current Price

$61.51

Market Cap

8.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OTEX
CYTK
Founded
1991
1997
Country
Canada
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.1B
8.3B
IPO Year
1998
2004

Fundamental Metrics

Financial Performance
Metric
OTEX
CYTK
Price
$25.01
$61.51
Analyst Decision
Hold
Strong Buy
Analyst Count
10
17
Target Price
$37.50
$86.12
AVG Volume (30 Days)
2.8M
1.7M
Earning Date
05-05-2026
05-25-2026
Dividend Yield
4.49%
N/A
EPS Growth
N/A
3.49
EPS
1.24
N/A
Revenue
$2,815,241,000.00
$13,368,000.00
Revenue This Year
$2.80
$37.53
Revenue Next Year
$1.05
$214.81
P/E Ratio
$19.74
N/A
Revenue Growth
22.88
N/A
52 Week Low
$22.44
$29.31
52 Week High
$39.90
$70.98

Technical Indicators

Market Signals
Indicator
OTEX
CYTK
Relative Strength Index (RSI) 43.87 42.82
Support Level $22.44 $59.23
Resistance Level $28.60 $65.93
Average True Range (ATR) 0.98 2.55
MACD 0.31 -0.25
Stochastic Oscillator 45.09 12.94

Price Performance

Historical Comparison
OTEX
CYTK

About OTEX Open Text Corporation

Open Text Corp is engaged in the design, development, marketing, and sale of Information Management software and solutions. Its software allows clients to archive, aggregate, retrieve, and search unstructured information (such as documents, e-mail, and presentations). Its platform and services provide secure and scalable solutions for enterprises, SMBs, governments, and consumers around the world. The company's solutions are marketed and delivered on the OpenText Cloud Platform, which is a comprehensive Information Management platform consisting of six business clouds; Content Cloud, Cybersecurity Cloud, Application Automation Cloud, Business Network Cloud, IT Operations Management Cloud, and Analytics Cloud. Geographically, it derives maximum revenue from the United States.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: